About Index Trending news
Lists
Pricing
Effector Therapeutics

Effector Therapeutics

Effector Therapeutics

Effector Therapeutics is an early-stage company focused on the discovery anddevelopment of small molecule cancer therapeutics.

Elsewhere

Alexa global traffic share

24 Jul 2017
$38,600,000
Venture capital (Series C)

Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs

Xconomy
+1
20 May 2013